The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

March 31, 2006

Conditions
Heart Failure, Congestive
Interventions
DRUG

Eplerenone

Trial Locations (53)

10032

Pfizer Investigational Site, New York

11030

Pfizer Investigational Site, Manhasset

11795

Pfizer Investigational Site, West Islip

12205

Pfizer Investigational Site, Albany

18840

Pfizer Investigational Site, Sayre

19104

Pfizer Investigational Site, Philadelphia

19107

Pfizer Investigational Site, Philadelphia

24014

Pfizer Investigational Site, Roanoke

24333

Pfizer Investigational Site, Galax

27030

Pfizer Investigational Site, Mount Airy

27109

Pfizer Investigational Site, Winston-Salem

29401

Pfizer Investigational Site, Charleston

30014

Pfizer Investigational Site, Covington

30901

Pfizer Investigational Site, Augusta

32209

Pfizer Investigational Site, Jacksonville

32216

Pfizer Investigational Site, Jacksonville

33308

Pfizer Investigational Site, Fort Lauderdale

37212

Pfizer Investigational Site, Nashville

38138

Pfizer Investigational Site, Germantown

44053

Pfizer Investigational Site, Lorain

45219

Pfizer Investigational Site, Cincinnati

46202

Pfizer Investigational Site, Indianapolis

46260

Pfizer Investigational Site, Indianapolis

48105

Pfizer Investigational Site, Ann Arbor

48201

Pfizer Investigational Site, Detroit

53792

Pfizer Investigational Site, Madison

55415

Pfizer Investigational Site, Minneapolis

55422

Pfizer Investigational Site, Minneapolis

61701

Pfizer Investigational Site, Bloomington

61761

Pfizer Investigational Site, Normal

63104

Pfizer Investigational Site, St Louis

63110

Pfizer Investigational Site, St Louis

63117

Pfizer Investigational Site, St Louis

68516

Pfizer Investigational Site, Lincoln

68850

Pfizer Investigational Site, Lexington

69001

Pfizer Investigational Site, McCook

73120

Pfizer Investigational Site, Oklahoma City

77030

Pfizer Investigational Site, Houston

77630

Pfizer Investigational Site, Beaumont

77702

Pfizer Investigational Site, Beaumont

80262

Pfizer Investigational Site, Denver

94546

Pfizer Investigational Site, Castro Valley

95403

Pfizer Investigational Site, Santa Rosa

92103-8411

Pfizer Investigational Site, San Diego

94598-3084

Pfizer Investigational Site, Walnut Creek

06510

Pfizer Investigational Site, New Haven

30309-1721

Pfizer Investigational Site, Atlanta

83704-0107

Pfizer Investigational Site, Boise

04210

Pfizer Investigational Site, Auburn

63110-0250

Pfizer Investigational Site, St Louis

03756

Pfizer Investigational Site, Lebanon

44870-3390

Pfizer Investigational Site, Sandusky

02860

Pfizer Investigational Site, Pawtucket

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00082589 - The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure | Biotech Hunter | Biotech Hunter